User profiles for Chee Keng Mok

Chee-Keng Mok

Biosafety Level 3 Platform, A*STAR Infectious Diseases Labs
Verified email at idlabs.a-star.edu.sg
Cited by 778

[HTML][HTML] Genomic signatures of human versus avian influenza A viruses

GW Chen, SC Chang, CK Mok, YL Lo… - Emerging infectious …, 2006 - ncbi.nlm.nih.gov
Position-specific entropy profiles created from scanning 306 human and 95 avian influenza
A viral genomes showed that 228 of 4,591 amino acid residues yielded significant …

Current perspective of antiviral strategies against COVID-19

BA Ahidjo, MWC Loe, YL Ng, CK Mok… - ACS infectious …, 2020 - ACS Publications
COVID-19 was declared a pandemic by the World Health Organization on March 11, 2020.
This novel coronavirus disease, caused by the SARS-CoV-2 virus, has resulted in severe …

Calcitriol, the active form of vitamin D, is a promising candidate for COVID-19 prophylaxis

CK Mok, YL Ng, BA Ahidjo, RC Hua Lee, MW Choy Loe… - BioRxiv, 2020 - biorxiv.org
COVID-19, the disease caused by SARS-CoV-2 ( 1 ), was declared a pandemic by the World
Health Organization (WHO) in March 2020 ( 2 ). While awaiting a vaccine, several antivirals …

[HTML][HTML] Antiviral natural products for arbovirus infections

VSL Goh, CK Mok, JJH Chu - Molecules, 2020 - mdpi.com
Over the course of the last 50 years, the emergence of several arboviruses have resulted in
countless outbreaks globally. With a high proportion of infections occurring in tropical and …

Airborne SARS‐CoV‐2 surveillance in hospital environment using high‐flowrate air samplers and its comparison to surface sampling

…, DI Drautz‐Moses, PA Tambyah, CK Mok… - Indoor …, 2022 - Wiley Online Library
Reliable methods to detect the presence of SARS‐CoV‐2 at venues where people gather
are essential for epidemiological surveillance to guide public policy. Communal screening of …

[HTML][HTML] AAV-CRISPR-Cas13 eliminates human enterovirus and prevents death of infected mice

CT Keng, T Yogarajah, RCH Lee, IBH Muhammad… - …, 2023 - thelancet.com
Background RNA viruses account for many human diseases and pandemic events but are
often not targetable by traditional therapeutics modalities. Here, we demonstrate that adeno-…

[HTML][HTML] Evaluation of in vitro and in vivo antiviral activities of vitamin D for SARS-CoV-2 and variants

CK Mok, YL Ng, BA Ahidjo, ZQ Aw, H Chen, YH Wong… - Pharmaceutics, 2023 - mdpi.com
The COVID-19 pandemic has brought about unprecedented medical and healthcare challenges
worldwide. With the continual emergence and spread of new COVID-19 variants, four …

Laboratory-based surveillance and molecular epidemiology of influenza virus in Taiwan

…, KC Tsao, CG Huang, YL Huang, CK Mok… - Journal of clinical …, 2005 - Am Soc Microbiol
A laboratory-based surveillance network of 11 clinical virological laboratories for influenza
viruses was established in Taiwan under the coordination of the Center for Disease Control …

[HTML][HTML] A potent and protective human neutralizing antibody against SARS-CoV-2 variants

S Shan, CK Mok, S Zhang, J Lan, J Li, Z Yang… - Frontiers in …, 2021 - frontiersin.org
As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to
emerge and spread around the world, antibodies and vaccines to confer broad and potent …

[HTML][HTML] A blood RNA transcriptome signature for COVID-19

…, GB Cross, CM Naftalin, BA Ahidjo, CK Mok… - BMC medical …, 2021 - Springer
Background COVID-19 is a respiratory viral infection with unique features including a more
chronic course and systemic disease manifestations including multiple organ involvement; …